CoChat

The SORL1 gene and convergent neural risk for Alzheimer’s disease across the human lifespan

Open access
Felsky, D, Szeszko, P, Yu, L, Honer, W G, De Jager, P L, Schneider, J A, Malhotra, A K, Lencz, T, Ikuta, T, Pipitone, J, Chakravarty, M M, Lobaugh, N J, Mulsant, B H, Pollock, B G, Kennedy, J L, Bennett, D A, Voineskos, A N · 2014 · Molecular Psychiatry
Cited by 42

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Prior to intervention trials in individuals genetically at-risk for late-onset Alzheimer’s disease, critical first steps are identifying where (neuroanatomic effects), when (timepoint in the lifespan) and how (gene expression and neuropathology) Alzheimer’s risk genes impact the brain. We hypothesized that variants in the sortilin-like receptor (SORL1) gene would affect multiple Alzheimer’s phenotypes before the clinical onset of symptoms. Four independent samples were analyzed to determine effects of SORL1 genetic risk variants across the lifespan at multiple phenotypic levels: (1) microstructural integrity of white matter using diffusion tensor imaging in two healthy control samples (n=118, age 18–86; n=68, age 8–40); (2) gene expression using the Braincloud postmortem healthy control sample (n=269, age 0–92) and (3) Alzheimer’s neuropathology (amyloid plaques and tau tangles) using a postmortem sample of healthy, mild cognitive impairment (MCI) and Alzheimer’s individuals (n=710, age 66–108). SORL1 risk variants predicted lower white matter fractional anisotropy in an age-independent manner in fronto-temporal white matter tracts in both samples at 5% family-wise error-corrected thresholds. SORL1 risk variants also predicted decreased SORL1 mRNA expression, most prominently during childhood and adolescence, and significantly predicted increases in amyloid pathology in postmortem brain. Importantly, the effects of SORL1 variation on both white matter microstructure and gene expression were observed during neurodevelopmental phases of the human lifespan. Further, the neuropathological mechanism of risk appears to primarily involve amyloidogenic pathways. Interventions targeted toward the SORL1 amyloid risk pathway may be of greatest value during early phases of the lifespan.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/mp.2013.142

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 42

Metadata

Authors
Felsky, D., Szeszko, P., Yu, L., Honer, W. G., De Jager, P. L., Schneider, J. A., Malhotra, A. K., Lencz, T., Ikuta, T., Pipitone, J., Chakravarty, M. M., Lobaugh, N. J., Mulsant, B. H., Pollock, B. G., Kennedy, J. L., Bennett, D. A., & Voineskos, A. N.
Venue
Molecular Psychiatry
Published
2013-10-29
Volume
19
Issue
10
Pages
1125-1132
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W1994457811
Cited by
42
References
19
FWCI
3.47
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.